The cost burden of metastatic prostate cancer in the US populations covered by employer-sponsored health insurance.
Saved in:
| Title: | The cost burden of metastatic prostate cancer in the US populations covered by employer-sponsored health insurance. |
|---|---|
| Authors: | Horný M; School of Medicine, Emory University, Atlanta, Georgia, USA.; Rollins School of Public Health, Emory University, Atlanta, Georgia, USA., Yabroff KR; Health Services Research, and Health Equity Science, American Cancer Society, Atlanta, Georgia, USA., Filson CP; School of Medicine, Emory University, Atlanta, Georgia, USA.; Winship Cancer Institute, Emory Healthcare, Atlanta, Georgia, USA.; Urology Service Line, Atlanta Veterans Affairs Medical Center, Decatur, Georgia, USA., Zheng Z; Health Services Research, and Health Equity Science, American Cancer Society, Atlanta, Georgia, USA., Ekwueme DU; Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Richards TB; Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Howard DH; Rollins School of Public Health, Emory University, Atlanta, Georgia, USA. |
| Source: | Cancer [Cancer] 2023 Oct 15; Vol. 129 (20), pp. 3252-3262. Date of Electronic Publication: 2023 Jun 17. |
| Publication Type: | Journal Article; Research Support, U.S. Gov't, P.H.S. |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
